BGM
BGM
NASDAQ · Pharmaceuticals

Bgm Group Ltd

$0.58
+0.03 (+5.93%)
As of Mar 25, 3:46 PM ET ·
Financial Highlights (FY 2025)
Revenue
101.37M
Net Income
12.48M
Gross Margin
33.1%
Profit Margin
12.3%
Rev Growth
+16.4%
D/E Ratio
0.21
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 33.1% 33.1% 33.1%
Operating Margin 14.7% 16.8% 14.4%
Profit Margin 12.3% 11.7% 12.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 101.37M 106.35M 109.96M
Gross Profit 33.57M 35.22M 36.42M
Operating Income 14.88M 17.84M 15.80M
Net Income 12.48M 12.42M 13.50M
Gross Margin 33.1% 33.1% 33.1%
Operating Margin 14.7% 16.8% 14.4%
Profit Margin 12.3% 11.7% 12.3%
Rev Growth +16.4% +7.5% +6.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 24.16M 23.86M 26.94M
Total Equity 113.51M 126.32M 122.05M
D/E Ratio 0.21 0.19 0.22
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 20.71M 22.69M 21.79M
Free Cash Flow 8.96M 8.29M 10.61M